NO154494C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.

Info

Publication number
NO154494C
NO154494C NO820779A NO820779A NO154494C NO 154494 C NO154494 C NO 154494C NO 820779 A NO820779 A NO 820779A NO 820779 A NO820779 A NO 820779A NO 154494 C NO154494 C NO 154494C
Authority
NO
Norway
Prior art keywords
fluorprostacyclines
preparation
therapeutic active
analogy procedure
analogy
Prior art date
Application number
NO820779A
Other languages
English (en)
Norwegian (no)
Other versions
NO820779L (no
NO154494B (no
Inventor
George William Holland
Perry Rosen
Hans Maag
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO820779L publication Critical patent/NO820779L/no
Publication of NO154494B publication Critical patent/NO154494B/no
Publication of NO154494C publication Critical patent/NO154494C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
NO820779A 1981-03-11 1982-03-10 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner. NO154494C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24281881A 1981-03-11 1981-03-11
US33779182A 1982-01-07 1982-01-07

Publications (3)

Publication Number Publication Date
NO820779L NO820779L (no) 1982-09-13
NO154494B NO154494B (no) 1986-06-23
NO154494C true NO154494C (no) 1986-10-01

Family

ID=26935366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820779A NO154494C (no) 1981-03-11 1982-03-10 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.

Country Status (19)

Country Link
AT (1) AT381308B (hu)
AU (2) AU558000B2 (hu)
CA (1) CA1208634A (hu)
CH (2) CH648556A5 (hu)
DE (1) DE3208880A1 (hu)
DK (1) DK104882A (hu)
ES (1) ES510286A0 (hu)
FR (3) FR2503161B1 (hu)
GB (2) GB2094310B (hu)
HU (1) HU190684B (hu)
IE (1) IE52388B1 (hu)
IL (1) IL65177A (hu)
IT (1) IT1195917B (hu)
LU (1) LU83992A1 (hu)
NL (1) NL8200992A (hu)
NO (1) NO154494C (hu)
NZ (1) NZ199912A (hu)
PH (2) PH17410A (hu)
SE (2) SE453294B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190007B (en) * 1982-05-06 1986-08-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for producing new aromatic prostacylin analogues
DK40485A (da) * 1984-03-02 1985-09-03 Hoffmann La Roche Prostaglandin-mellemprodukter
US4634782A (en) * 1985-06-24 1987-01-06 Hoffmann-La Roche Inc. 7-fluoro-dihydro PGI compounds
US4680415A (en) * 1985-06-24 1987-07-14 Hoffmann-La Roche Inc. Intermediates for 7-fluoro dihydro PGI compounds
CH674363A5 (hu) * 1986-12-01 1990-05-31 Hoffmann La Roche
US4808734A (en) * 1986-12-01 1989-02-28 Hoffmann-La Roche Inc. 16-cycloalkyl-7-fluoro-prostacyclins
RU2239925C1 (ru) * 2003-09-03 2004-11-10 Анисимова Ирина Александровна Свеча зажигания для двигателя внутреннего сгорания

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
DE2811950A1 (de) * 1978-03-18 1979-12-13 Hoechst Ag Neue analoga von prostacyclin
US4254042A (en) * 1979-07-05 1981-03-03 The Upjohn Company 19-Hydroxy-19-methyl-4,5-didehydro-PGI1 compounds
WO1981001002A1 (en) * 1979-10-10 1981-04-16 Univ Chicago Fluoro-substituted prostaglandins and prostacyclins
GB2084991B (en) * 1980-09-22 1984-06-20 Hoffmann La Roche Prostacyclins
GB2088856B (en) * 1980-10-27 1984-06-27 Chinoin Gyogyszer Es Vegyeszet 7-substituted pg12-derivatives their preparation and pharmaceutical compositions containing them
EP0054795B1 (en) * 1980-12-09 1987-07-15 Teijin Limited Novel halogenated prostacyclins, process for the production thereof, and pharmaceutical use thereof

Also Published As

Publication number Publication date
CA1208634A (en) 1986-07-29
NZ199912A (en) 1985-08-30
IE820547L (en) 1982-09-11
AU558000B2 (en) 1987-01-15
PH17410A (en) 1984-08-08
PH18584A (en) 1985-08-12
IT1195917B (it) 1988-11-03
ES8304934A1 (es) 1983-04-01
GB8426077D0 (en) 1984-11-21
GB2094310B (en) 1985-07-03
CH651033A5 (de) 1985-08-30
SE453294B (sv) 1988-01-25
GB2158822B (en) 1986-06-18
IL65177A0 (en) 1982-05-31
AU6855587A (en) 1987-05-07
NL8200992A (nl) 1982-10-01
GB2158822A (en) 1985-11-20
IE52388B1 (en) 1987-10-14
ATA94982A (de) 1986-02-15
IT8219966A0 (it) 1982-03-04
AU576441B2 (en) 1988-08-25
FR2515644A1 (fr) 1983-05-06
HU190684B (en) 1986-10-28
IL65177A (en) 1985-10-31
NO820779L (no) 1982-09-13
SE8703023D0 (sv) 1987-07-31
FR2515650A1 (fr) 1983-05-06
FR2515650B1 (fr) 1985-08-09
ES510286A0 (es) 1983-04-01
NO154494B (no) 1986-06-23
DE3208880A1 (de) 1982-09-23
LU83992A1 (de) 1983-11-17
SE8201506L (sv) 1982-09-12
FR2503161A1 (fr) 1982-10-08
FR2515644B1 (hu) 1984-05-25
FR2503161B1 (fr) 1986-04-18
SE8703023L (sv) 1987-07-31
DK104882A (da) 1982-09-12
AT381308B (de) 1986-09-25
AU8115682A (en) 1982-09-16
GB2094310A (en) 1982-09-15
CH648556A5 (de) 1985-03-29

Similar Documents

Publication Publication Date Title
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO161065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO156693C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-propynylsteroider.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO164415C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO811346L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.